Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.037,59
1,06%
NASDAQ
20.020,36
-0,05%
Bitcoin
96.145,20
0,48%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeneDx Holdings Corporation (WGS) GeneDx Holdings Corporation (WGS) Notizie

GeneDx Holdings Corporation

WGS
80,00
2,60 (3,36%)
27 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202422:05BWGeneDx to Present at the 43rd Annual J.P. Morgan Healthcare..
05/12/202414:30BWGeneDx to Expand Access to Exome Testing for Pediatric..
22/11/202422:05BWGeneDx to Participate in Upcoming Investor Conference
19/11/202414:30BWGeneDx Fuels Rare Disease Drug Discovery with Launch of..
18/11/202414:30BWGeneDx Announces Heidi Chen as Chief Legal Officer and..
07/11/202422:35BWNew GeneDx Study Reveals Racial Disparities in Genetic..
04/11/202422:35BWGeneDx to Highlight Key Research Findings at American..
29/10/202413:00BWGeneDx Reports Third Quarter 2024 Financial Results and..
24/10/202417:10BWGroundbreaking GUARDIAN Study Shows Benefits of Adding..
08/10/202414:30BWGeneDx to Showcase Data from Largest Genomic Newborn..
03/10/202422:05BWGeneDx to Report Third Quarter 2024 Financial Results on..
27/9/202422:05BWGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
04/9/202403:35EDGAR2Form 144 - Report of proposed sale of securities
12/8/202422:05BWGeneDx to Participate in Fall Investor Conferences
09/8/202422:05BWGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
31/7/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202422:12EDGAR2Form 8-K - Current report
30/7/202422:05BWGeneDx Reports Second Quarter 2024 Financial Results and..
30/7/202412:06IHMARKETNEWSU.S. Futures Climb Before Fed Meeting; Oil Prices Drop on..
11/7/202422:05GLOBEGeneDx to Report Second Quarter 2024 Financial Results on..
10/6/202414:30GLOBEGeneDx Announces Collaboration with Epic Aura to Expand..
05/6/202413:00GLOBEGeneDx Announces Patient Access Program to Expand Access to..
22/5/202422:05GLOBEGeneDx to Participate in Upcoming Investor Conferences
29/4/202422:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/4/202414:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04/4/202422:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/3/202413:30GLOBEGeneDx to Present Data at the 2024 American College of..
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
23/2/202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202422:28EDGAR2Form 8-K - Current report
20/2/202422:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01/2/202422:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24/1/202422:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
23/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:58EDGAR2Form 8-K - Current report
08/1/202414:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
04/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 77,37 Min: 76,70 Max: 81,90
Chiusura: 77,40

La tua Cronologia

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network